Mendelian Susceptibility to Mycobacterial Diseases
Authors:
M. Bloomfield 1; E. Havránková 1; H. Houšťková 1; P. Kabíček 1; K. Křepela 1; A. Šedivá 2; J. Bustamante 3
Authors place of work:
Pediatrická klinika IPVZ, 1. LF UK a Thomayerova nemocnice, Praha, přednostka doc. MUDr. H. Houšťková, CSc.
1; Ústav imunologie 2. LF UK a FN Motol, Praha, přednostka prof. MUDr. J. Bartůňková, DrSc.
2; Laboratoire de Génétique Humaine des Maladies Infectieuses, Institut National de la Santé et de la Recherche Médicale et Université Paris Descartes, France, vedoucí prof. J. L. Casanova, MD, Ph. D
3
Published in the journal:
Čes-slov Pediat 2016; 71 (7-8): 340-344.
Category:
Tuberculosis
Kazuistika první pacientky byla přednesena na XI. českém pediatrickém kongresu 20. září 2014.
Summary
Mendelian Susceptibility to Mycobacterial Diseases (MSMD) encompasses a newly emerged group of monogenic primary immunodeficiencies caused by defects in IL12-IL23/IFNγ mediated mononuclear phagocyte-Th1 communication pathway. Patients typically display various degree of selective impairment of immunity against mycobacteria (particularly against weakly virulent strains) and nontyphoid salmonellae; other aspects of host defence remain intact. Depending on the specific mutation, the clinical presentation ranges from mild adverse reactions to BCG vaccine to life-threatening disseminated mycobacterial infections and salmonellosis. The following case review reports on first two patients diagnosed with MSMD in the Czech Republic: a girl with IFNγ receptor mutation and a boy with STAT1 loss of function mutation.
Key words:
mendelian susceptibility to mycobacterial diseases, interleukin 12 (IL12), interferon gamma (IFNγ), STAT1, BCG, nontuberculous mycobacteria
Zdroje
1. Bustamante J, Boisson-Dupuis S, Abel L, et al. Mendelian susceptibility to mycobacterial disease: Genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin Immunol 2014; 26:454–470.
2. Al-Muhsen S, Casanova J. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol 2008; 122:1043–1051.
3. Filipé-Santos O, et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006; 18: 347–361.
4. Fieschi C, et al. High levels of interferon gamma in the plasma of children with complete interferon gamma receptor deficiency. Pediatrics 2001; 107: E48.
5. Moilanen P, Korppi M, Hovi L, et al. Succesful hemopoietic stem cell transplantation from an unrelated donor in a child with interferon gamma receptor deficiency. Pediatr Infect Dis J 2009; 28: 658–660.
6. Roesler J, Picard C., Borgioni P, et al. Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey. J Pediatr 2004; 145: 806–812.
7. Kanako T, Toshinao K, Yumiko N. Augmentation of antitubercular therapy with IFNγ in a patient withdominant partial IFNγ receptor 1 deficiency. Clin Immun 2014; 151: 25–28.
8. Dorman S, Picard C, Lammas D, et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 2004; 364: 2113–2121.
9. Boisson-Dupuis S, Abel L, Casanova J. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr Opin Immunol 2012; 24 (4): 364–378.
10. Chapgier A, et al. A partial form of recessive STAT1 deficiency in humans. J Clin Invest 2009; 109: 1502–1514.
11. Chapgier A, et al. Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet 2006; 2: e131.
12. Newport M, Huxley C, Huston S, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335: 1941–1949.
13. Casanova J. Severe infectious diseases of childhood as monogenic inborn errors of imunity. PNAS 2015; 112 (51): E7128–E7137.
14. Casanova J, Abel L. The genetic theory of infectious diseases: a brief history and selected illustrations. Annual Rev Genomics Hum Genet 2013; 14: 215–243.
Štítky
Neonatology Paediatrics General practitioner for children and adolescentsČlánok vyšiel v časopise
Czech-Slovak Pediatrics
2016 Číslo 7-8
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
Najčítanejšie v tomto čísle
- TB meningitis in the Czech Republic – new encounter with an old diagnosis after 20 years
- The current situation in children TB in Slovakia
- Incidence of tuberculosis at children in the Czech Republic in years 2000–2015
- Tuberculosis in Children – some issues